ConvaTec Group PLC 2CVU.F Stock
ConvaTec Group PLC Price Chart
ConvaTec Group PLC 2CVU.F Financial and Trading Overview
ConvaTec Group PLC stock price | 12.8 EUR |
Previous Close | 9.1 EUR |
Open | 9.2 EUR |
Bid | 9.2 EUR x N/A |
Ask | 10.1 EUR x N/A |
Day's Range | 9.2 - 9.2 EUR |
52 Week Range | 8.4 - 10.9 EUR |
Volume | 200 EUR |
Avg. Volume | 0 EUR |
Market Cap | 4.88B EUR |
Beta (5Y Monthly) | 0.684674 |
PE Ratio (TTM) | 83.63636 |
EPS (TTM) | 0.24 EUR |
Forward Dividend & Yield | 0.23 (2.44%) |
Ex-Dividend Date | April 11, 2023 |
1y Target Est | N/A |
2CVU.F Valuation Measures
Enterprise Value | 5.83B EUR |
Trailing P/E | 83.63636 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.3550847 |
Price/Book (mrq) | 2.9040403 |
Enterprise Value/Revenue | 2.813 |
Enterprise Value/EBITDA | 13.565 |
Trading Information
ConvaTec Group PLC Stock Price History
Beta (5Y Monthly) | 0.684674 |
52-Week Change | -1.086% |
S&P500 52-Week Change | 20.43% |
52 Week High | 10.9 EUR |
52 Week Low | 8.4 EUR |
50-Day Moving Average | 9.4 EUR |
200-Day Moving Average | 9.7 EUR |
2CVU.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 511.4M |
Float | 401.86M |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 0.33% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.06 |
Trailing Annual Dividend Yield | 0.65% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 1.782 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 3.03% |
Operating Margin (ttm) | 12.34% |
Gross Margin | 53.91% |
EBITDA Margin | 20.73% |
Management Effectiveness
Return on Assets (ttm) | 4.40% |
Return on Equity (ttm) | 3.80% |
Income Statement
Revenue (ttm) | 2.07B EUR |
Revenue Per Share (ttm) | 4.1 EUR |
Quarterly Revenue Growth (yoy) | -0.20% |
Gross Profit (ttm) | 1.12B EUR |
EBITDA | 429.8M EUR |
Net Income Avi to Common (ttm) | 62.9M EUR |
Diluted EPS (ttm) | 0.11 |
Quarterly Earnings Growth (yoy) | -54.10% |
Balance Sheet
Total Cash (mrq) | 145.8M EUR |
Total Cash Per Share (mrq) | 0.29 EUR |
Total Debt (mrq) | 1.3B EUR |
Total Debt/Equity (mrq) | 80.79 EUR |
Current Ratio (mrq) | 1.668 |
Book Value Per Share (mrq) | 3.168 |
Cash Flow Statement
Operating Cash Flow (ttm) | 281.7M EUR |
Levered Free Cash Flow (ttm) | 222.89M EUR |
Profile of ConvaTec Group PLC
Country | Germany |
State | N/A |
City | Reading |
Address | 3 Forbury Place |
ZIP | RG1 3JH |
Phone | 44 11 8952 8100 |
Website | https://www.convatecgroup.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 10036 |
ConvaTec Group PLC engages in the development, manufacture, and marketing of medical products and technologies worldwide. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence and critical care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.
Q&A For ConvaTec Group PLC Stock
What is a current 2CVU.F stock price?
ConvaTec Group PLC 2CVU.F stock price today per share is 12.8 EUR.
How to purchase ConvaTec Group PLC stock?
You can buy 2CVU.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ConvaTec Group PLC?
The stock symbol or ticker of ConvaTec Group PLC is 2CVU.F.
Which industry does the ConvaTec Group PLC company belong to?
The ConvaTec Group PLC industry is Medical Instruments & Supplies.
How many shares does ConvaTec Group PLC have in circulation?
The max supply of ConvaTec Group PLC shares is 530.04M.
What is ConvaTec Group PLC Price to Earnings Ratio (PE Ratio)?
ConvaTec Group PLC PE Ratio is 53.33333600 now.
What was ConvaTec Group PLC earnings per share over the trailing 12 months (TTM)?
ConvaTec Group PLC EPS is 0.24 EUR over the trailing 12 months.
Which sector does the ConvaTec Group PLC company belong to?
The ConvaTec Group PLC sector is Healthcare.